Mursla is harnessing exosome biology with its breakthrough ExoPheno™ platform to gain novel insights into diseases.
New logo symbolises the secretion of an exosome from its parental cell along with its markers of origin.
Who are we?
Mursla is a breakthrough exosome characterisation company based on a novel proprietary technology platform, ExoPheno™, which detects the multi-omics cargo of tissue-specific exosomes in blood for various biomedical applications. Exosomes, also known as Extracellular Vesicles, have been shown to reflect the state of their cellular sources, transporting specific ‘-omics’ information (DNA, RNA, proteins, lipids and metabolites) either locally or to distant sites via the circulatory system, including blood.
Discover more: mursla.com